INTS vs TRMB
Intensity Therapeutics, Inc. Common stock (INTS) versus Trimble Inc (TRMB) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Trimble Inc (TRMB) is a scientific & technical instruments company listed on NASDAQ.
INTS does not have a complete income-statement cache yet.
Latest reported TRMB revenue for 2025-01-03 was $3.68B. Net income was $1.50B. Revenue was down 3.0% from 2023-12-29 to 2025-01-03. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
INTS currently screens at market cap $7.7M. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
Not investment advice. Open the INTS and TRMB stock pages for the full models.
Not investment advice.